Just saw that Capital One posted IB applications for capital markets (leveraged finance, derivatives, structured products) and M&A (Kipps and Triple Tree).
Does anyone have any insight into their presence and maybe growth trajectory? Would starting off in capital markets there be a good opportunity to get one’s foot in the door? Thanks!
| +355 | Evercore Intern Seizure | 54 | 7h |
| +67 | JPM M&A is Gone??? Purely Coverage Banking??? | 31 | 6h |
| +58 | Is DCM actually underrated ? | 24 | 17h |
| +50 | How do I understand vs. just memorizing? | 5 | 16h |
| +48 | Losing my personality in Banking | 9 | 17h |
| +47 | Are all Tech / TMT groups sweaty? | 38 | 13h |
| +42 | Associate & Above IB exits | 16 | 3d |
| +32 | Incoming IB Analyst: Best Ways to Prepare? | 10 | 9h |
| +27 | Which groups are ideal for laterals? | 12 | 11h |
| +24 | The good and bad with Wells Fargo | 1 | 17h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Anything is better than nothing man
Small IB group within CapitalOne itself, TripleTree and Kipps are much more established and do very well in their respective niches. TT in particular kills it in the MM Healthcare IT and Tech verticals and seems to be winning larger mandates recently. Comp is street (if not slightly higher) so great place to be if you value deal reps and don’t care about prestige.
Thanks for the reply. Do you think it’s a place that could allow for lateral opportunities to other banks down the line?
TT gives you a lot of lateral opportunities or even MM PE placement, but will be wary that there’s a massive waiting list for Analysts to change to NY office, so you will most likely be in Minneapolis for at least a year.
Bump, also interested
TT and Kipps are both established in their fields and they are focusing on growing the financing side. They have a pretty large balance sheet so they are able to get in on some pretty big syndications and structured deals. Have started to be lead on a few and seem to be on an upward trajectory.
COS has done a few lead left/joint book runner deals and from what I see they are lean and effective. TT’s presence in Healthcare & IT is reputable and their NYC headcount is growing. Kipps is an established ADG player on the sell-side with an upside in growth since more PE shops are buying.
Do you think the capital markets side has a longer term growth trajectory or best to look elsewhere?
anyone heard abt interviews?
No word but I heard via a VP that the process should be fast
Did the SA interview process with C1, whole process took less than a month.
What did it look like? How many rounds/was it very technical?
Kipps and TT do well in the middle market with regards to their mandate (A&D and healthcare).
anyone willing to chat about TT?
Placeat ex vero vel quasi. Nobis voluptas esse quia magni expedita sunt vitae. Quia est et voluptatibus odit aut a. Ad laboriosam quia nemo facilis ipsa sit perferendis. Sit aperiam voluptatem nihil exercitationem perspiciatis odit alias. Sed reiciendis provident quam laudantium. Porro rerum molestiae quisquam similique qui assumenda.
Itaque veritatis consequatur ratione pariatur hic laborum suscipit. Aut perferendis nam ut neque voluptatem. Unde ex aut iure. Provident dolores quaerat quos doloremque quia.
Libero reprehenderit natus pariatur totam nesciunt. Tempora esse id omnis veritatis culpa.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...